Spencer Jennifer C, Zhang Hanwen, Charlton Brittany M, Schnarrs Phillip W, Kuehne Felicitas, Siebert Uwe, Trentham-Dietz Amy, Shokar Navkiran K, Kim Jane J, Pignone Michael P
Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, TX, United States of America; Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, TX, United States of America; Texas Institute for Sexual and Gender Minority Health Research, Austin, TX, United States of America.
Health Outcomes Division, College of Pharmacy, University of Texas at Austin, Austin, TX, United States of America.
Prev Med. 2025 May;194:108262. doi: 10.1016/j.ypmed.2025.108262. Epub 2025 Mar 15.
Women identifying as lesbian, gay, bisexual, or queer (LGBQ) have lower cervical cancer screening use and differences in care access. Less known about how differences vary by data sources and within LGBQ subgroups. We evaluated LGBQ disparities in cervical cancer screening use and risk factors across three national surveys in the United States.
Data were from the 2019 and 2021 National Health Interview Survey, the 2018 and 2020 Behavioral Risk Factor Surveillance Survey, and the 2017-2019 National Survey of Family Growth. We meta-analyzed self-reported cervical cancer screening to estimate pooled relative risks (pRR), comparing those identifying as LGBQ to those identifying as straight/heterosexual. We also evaluated differences in care access and behavioral risk factors by sexual identity.
Despite demographic differences across surveys, all three surveys demonstrated a small reduction in up-to-date cervical cancer screening for LGBQ vs. straight/heterosexual women (pRR = 0.91 [CI 0.89-0.93]). The screening gap was larger for gay/lesbian (pRR: 0.90 [0.85-0.94]) than bisexual women (pRR: 0.94 [0.92-0.97]) and largest at younger ages (pRR age 21-29: 0.89 [CI 0.85-0.93]). LGBQ women reported consistently lower access to care across multiple measures. Risk factors were mixed, including higher smoking rates and higher HPV vaccination coverage for LGBQ women vs. straight.
LGBQ women are less likely to be screened for cervical cancer. Closing disparities in care access and identifying feasible and acceptable screening interventions will help reduce these disparities. We must also ensure high-quality data collection to monitor disparities across and within key subgroups.
自我认定为女同性恋、男同性恋、双性恋或酷儿(LGBQ)的女性进行宫颈癌筛查的比例较低,且在获得医疗服务方面存在差异。对于这些差异如何因数据来源以及LGBQ亚群体的不同而有所变化,我们了解得较少。我们在美国的三项全国性调查中评估了LGBQ群体在宫颈癌筛查使用情况和风险因素方面的差异。
数据来自2019年和2021年的全国健康访谈调查、2018年和2020年的行为风险因素监测调查以及2017 - 2019年的全国家庭成长调查。我们对自我报告的宫颈癌筛查情况进行荟萃分析,以估计合并相对风险(pRR),将自我认定为LGBQ的女性与自我认定为异性恋的女性进行比较。我们还按性取向评估了在获得医疗服务和行为风险因素方面的差异。
尽管各项调查在人口统计学特征上存在差异,但所有三项调查均显示,与异性恋女性相比,LGBQ女性的最新宫颈癌筛查率略有下降(pRR = 0.91 [CI 0.89 - 0.93])。女同性恋者的筛查差距(pRR:0.90 [0.85 - 0.94])比双性恋女性(pRR:0.94 [0.92 - 0.97])更大,且在较年轻年龄段差距最大(21 - 29岁的pRR:0.89 [CI 0.85 - 0.93])。LGBQ女性在多项指标上报告称获得医疗服务的机会始终较低。风险因素参差不齐,包括LGBQ女性的吸烟率较高,而HPV疫苗接种覆盖率也高于异性恋女性。
LGBQ女性接受宫颈癌筛查的可能性较小。缩小在获得医疗服务方面的差距,并确定可行且可接受的筛查干预措施,将有助于减少这些差异。我们还必须确保高质量的数据收集,以监测关键亚群体之间及内部的差异。